Press release
Rising Prevalence Of Hereditary Colorectal Cancer Syndromes Fuels Growth In Intestine Cancer Therapeutics Market: A Significant Driver Propelling The Intestine Cancer Therapeutics Market In 2025
Intestine Cancer Therapeutics Market
What Is the Intestine Cancer Therapeutics Market Size and Projected Growth Rate?
The market size for therapeutics in intestine cancer has seen significant growth lately. The market is projected to expand from $14 billion in 2024 to reach $15.26 billion in 2025, portraying a compound annual growth rate (CAGR) of 9.0%. The surge during the historic period is a result of progressive advances in medical research, rise in cancer occurrence, the use of chemotherapy and radiation therapies, initiatives for screening and early detection, and breakthroughs in genetic and biomarker discoveries.
The market for therapeutics targeting intestinal cancer is projected to witness robust expansion in the upcoming years. The market is estimated to escalate to $21.15 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.5%. The forecasted growth can be credited to advancements in immunotherapy, precision medicine, personalized treatments, new targeted therapies, and application of artificial intelligence (AI) alongside patient-oriented strategies. The forecast period is expected to see trends such as liquid biopsy technologies, precision medication and biomarker research, combination therapies, patient-focused care, supportive therapies, and the use of minimally invasive surgical methods.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13231
What Are the Major Segments in the Intestine Cancer Therapeutics Market?
The intestine cancer therapeutics market covered in this report is segmented -
1) By Treatment Type: Immunotherapy, Chemotherapy, Other Treatments
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Hospitals, Homecare, Specialty Centers, Other Applications
Subsegments:
1) By Immunotherapy: Checkpoint Inhibitors, CAR T-Cell Therapy, Cancer Vaccines
2) By Chemotherapy: Adjuvant Chemotherapy, Neoadjuvant Chemotherapy, Palliative Chemotherapy
3) By Other Treatments: Targeted Therapy, Radiation Therapy, Surgery, Hormone Therapy
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13231&type=smp
What Are The Driving Intestine Cancer Therapeutics Market Evolution?
The escalation in hereditary colorectal cancer syndromes frequency is anticipated to foster the expansion of the intestinal cancer therapeutics market. Hereditary colorectal cancer syndromes, a cluster of genetic disorders that heighten the probability of colorectal cancer (cancer of the colon or rectum) development in an individual, significantly contribute to intestinal cancer therapeutics by offering information related to specific genetic mutations that drastically ramp up the odds of colorectal cancer development. For example, in July 2023, the Switzerland-based intergovernmental organization, the World Health Organization, projected that by 2040, the frequency of hereditary colorectal cancer will experience a substantial elevation, predicting 3.2 million new cases and 1.6 million annual deaths. This indicates a 63% surge in new cases and a 73% rise in the death rate compared to the present statistics. Thus, the heightening frequency of hereditary colorectal cancer syndromes is fuelling the expansion of the intestine cancer therapeutics market. An upsurge in the request for personalized medicine is projected to push the expansion of the intestinal cancer therapeutics market. Personalized medicine, a healthcare and medical treatment methodology that adapts medical verdicts, procedures, interventions, and drug treatments to a patient's exclusive characteristics, is highly useful in intestinal cancer therapeutics. With this method, the treatment approach is customized by studying patients' genetic and molecular features, resulting in enhanced treatment efficiency and diminished side effects. For instance, in 2022, according to the Personalized Medicine Coalition, a professional membership institution based in the US, the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration endorsed 37 new molecular entities (NMEs) in 2022. Out of these 35 therapeutic NMEs, about 34%, or 12, are acknowledged as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the escalating demand for personalized medicine propels the expansion of the intestinal cancer therapeutics market.
Which Firms Dominate The Intestine Cancer Therapeutics Market Segments?
Major companies operating in the intestine cancer therapeutics market report are Pfizer Inc., Johnson & Johnson Private Limited, Roche Holding AG, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Mylan N.V., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Cipla Inc., Aurobindo Pharma Limited, Lupin Limited
What Trends Are Driving Growth in The Intestine Cancer Therapeutics Market?
Leading businesses in the intestinal cancer therapy market are creating innovative solutions like Lonsurf and acquiring necessary authorizations in order to expand customer reach, raise sales, and boost revenue. LONSURF is a combined drug product consisting of trifluridine and tipiracil, specifically designed to treat adults living with metastatic colorectal cancer. In August 2023, for example, Taiho Oncology Inc., a U.S.-based pharmacological firm, gained approval for Lonsurf from the US Food and Drug Administration. The drug is distributed in a single oral tablet form. Trifluridine functions by inhibiting cancer cell proliferation, while tipiracil prolongs the effectiveness of trifluridine by safeguarding it from the body's natural breakdown processes. The authorization of Lonsurf allows patients suffering from metastatic colorectal and other eligible cancers access to a fresh treatment potentiality, which could enhance results and lift life quality.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/intestine-cancer-therapeutics-global-market-report
Which Is The Largest Region In The Intestine Cancer Therapeutics Market?
Asia-Pacific was the largest region in the intestine cancer therapeutics market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the intestine cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Intestine Cancer Therapeutics Market?
2. What is the CAGR expected in the Intestine Cancer Therapeutics Market?
3. What Are the Key Innovations Transforming the Intestine Cancer Therapeutics Industry?
4. Which Region Is Leading the Intestine Cancer Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Hereditary Colorectal Cancer Syndromes Fuels Growth In Intestine Cancer Therapeutics Market: A Significant Driver Propelling The Intestine Cancer Therapeutics Market In 2025 here
News-ID: 4025175 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
